Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin-Assisted Psychotherapy for Severe Alcohol Use Disorder
NCT07296094Phase 2Not yet recruiting
- Sponsor
- Brigham and Women's Hospital
- Start
- Nov 2026
- Primary completion
- Dec 2029
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of psilocybin in alcohol use disorder (AUD), sponsored by Brigham and Women's Hospital. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
psilocybin
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT07296094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07296094.